Tower Research Capital (TRC)’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.35M | Buy |
|
|||||
|
2024
Q1 | $30.8K | Sell |
|
|||||
|
2023
Q4 | $232K | Buy |
|
|||||
|
2023
Q3 | $30.5K | Sell |
|
|||||
|
2023
Q2 | $135K | Buy |
|
|||||
|
2023
Q1 | $65K | Sell |
|
|||||
|
2022
Q4 | $118K | Sell |
|
|||||
|
2022
Q3 | $131K | Sell |
|
|||||
|
2022
Q2 | $161K | Buy |
|
|||||
|
2022
Q1 | $192K | Sell |
|
|||||
|
2021
Q4 | $189K | Sell |
|
|||||
|
2021
Q3 | $357K | Buy |
|
|||||
|
2021
Q2 | $40K | Buy |
|
|||||
|
2021
Q1 | $8K | Buy |
|
|||||
|
2020
Q4 | $2K | Buy |
|